文献速递主动脉疾病

女性患者开窗与分支腔内主动脉弓修复术的结局:一项回顾性多中心分析

Fenestrated and Branched Endovascular Aortic Arch Repair Outcomes in Female Patients: A Retrospective Multicentre Analysis.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2025-03-22

该回顾性多中心分析纳入148例接受定制开窗或分支腔内主动脉弓修复(FB-Arch)的女性患者,技术成功率95.9%,30天死亡率为8.1%,卒中率为10.1%。非自体近端主动脉锚定区(nNPAL)和主动脉夹层与较低的卒中风险独立相关;随访48个月生存率为79.5%,免于非计划再干预率为53.9%。

要点

  • 女性FB-Arch患者30天死亡率为8.1%,技术成功率为95.9%。
  • nNPAL与主动脉夹层分别与较低的卒中风险独立相关。
  • 随访48个月生存率为79.5%,免于非计划再干预率为53.9%。

核心结论

  • 女性FB-Arch患者30天死亡率可接受,nNPAL和主动脉夹层与较低的卒中风险独立相关。
  • 随访期间近半数病例发生非计划再干预。

研究设计与样本

  • 回顾性分析,遵循STROBE指南,纳入2011年1月1日至2024年3月31日期间四家欧洲主动脉中心的连续女性患者。
  • 共纳入148例接受定制开窗或分支腔内主动脉弓修复(FB-Arch)装置(Cook Medical)的女性患者,平均年龄71.8±3.5岁。

主要发现

  • 平均主动脉直径61.9±4.2 mm,14.2%为急诊手术,5.4%为破裂,主动脉夹层率为38.5%(慢性35.8%,急性2.7%)。
  • 远端FB-Arch占23%,B-Arch占68.9%,F-Arch占27.7%,3.4%使用左锁骨下动脉分支装置,nNPAL率为60.1%。
  • 技术成功率为95.9%,30天死亡率为8.1%,呼吸衰竭(OR 0.36,95%CI 0.21-0.50;p<.001)和心包积液(OR 0.43,95%CI 0.43-0.82;p<.001)与30天死亡独立相关。
  • 卒中率为10.1%(6.1%为主要卒中,均为缺血性),外周动脉疾病为预测因素(OR 0.20,95%CI 0.04-0.39;p=.020),nNPAL(OR -0.22,95%CI -0.26至-0.02;p=.030)和主动脉夹层(OR -0.19,95%CI -0.24至-0.001;p=.040)与较低的卒中率相关。
  • 脊髓缺血率为3.4%;48个月时(平均随访20.6±9.4个月)生存率为79.5%(95%CI 74.7-84.3%),卒中(HR 5.3,95%CI 4.8-5.8;p=.002)和充血性心力衰竭(HR 6.1,95%CI 5.5-6.6;p=.003)与较低的生存率相关;48个月免于非计划再干预率为53.9%(95%CI 44.5-63.3%)。

临床怎么用

  • 急诊修复与不良事件无关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Data on females managed with fenestrated or branched endovascular aortic arch repair (FB-Arch) are limited. This study aimed to present the 30 day and follow up outcomes of FB-Arch in female patients. METHODS: A retrospective analysis (1 January 2011 to 31 March 2024) among four European aortic centres was conducted according to STROBE guidelines. Consecutive female patients managed with custom made FB-Arch devices (Cook Medical, Bloomington, IN, USA) were eligible. Primary outcomes were technical success and death and stroke at 30 days. Kaplan-Meier and Cox regression analyses were performed for follow up outcomes. RESULTS: The study included 148 females (mean age 71.8 ± 3.5 years; mean aortic diameter 61.9 ± 4.2 mm; 14.2% urgent; 5.4% ruptures). The aortic dissection rate was 38.5% (35.8% chronic; 2.7% acute). Distal FB-Arch was performed in 23%. B-Arch was used in 68.9% and F-Arch in 27.7%, while 3.4% were managed with a left subclavian artery branch device. The non-native proximal aortic landing (nNPAL) rate was 60.1%. Technical success was 95.9%. The 30 day mortality rate was 8.1%, with respiratory failure (odds ratio [OR] 0.36, 95% confidence interval [CI] 0.21 - 0.50; p < .001) and pericardial effusion (OR 0.43, 95% CI 0.43 - 0.82; p < .001) being independently related. The stroke rate was 10.1% (6.1% major; all ischaemic), with peripheral arterial disease as a predictor (OR 0.20, 95% CI 0.04 - 0.39; p = .020), and nNPAL (OR -0.22, 95% CI -0.26 - -0.02; p = .030) and aortic dissection (OR -0.19, 95% CI -0.24 - -0.001; p = .040) related to lower stroke rates. Urgent repair was not related to adverse events. The spinal cord ischaemia rate was 3.4%. At 48 months (mean follow up 20.6 ± 9.4 months), survival was 79.5% (95% CI 74.7 - 84.3%), with stroke (hazard ratio [HR] 5.3, 95% CI 4.8 - 5.8; p = .002) and congestive heart failure (HR 6.1, 95% CI 5.5 - 6.6; p = .003) being related to lower survival. Freedom from unscheduled re-interventions was 53.9% (95% CI 44.5 - 63.3%) at 48 months. CONCLUSION: Female patients managed with FB-Arch presented an acceptable 30 day mortality rate. nNPAL and aortic dissection were independently related to lower stroke risk. Unscheduled re-interventions affected almost half of cases during follow up.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Nana P, Haulon S, Tsilimparis N, et al. Fenestrated and Branched Endovascular Aortic Arch Repair Outcomes in Female Patients: A Retrospective Multicentre Analysis. Eur J Vasc Endovasc Surg. 2025. PMID: 40127885. doi:10.1016/j.ejvs.2025.03.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。